JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Investigador en el periodo 1986-2013
University of Southern Denmark
Odense, DinamarcaPublicaciones en colaboración con investigadores/as de University of Southern Denmark (7)
2022
-
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA
Blood, Vol. 139, Núm. 6, pp. 835-844
2021
-
Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO)
Haematologica, Vol. 106, Núm. 6, pp. 1725-1732
2019
-
Insights on Multiple Myeloma Treatment Strategies
HemaSphere, Vol. 3, Núm. 1
-
Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma
Blood, Vol. 134, Núm. 8, pp. 668-677
2014
-
European perspective on multiple myeloma treatment strategies in 2014
Oncologist, Vol. 19, Núm. 8, pp. 829-844
2011
-
Multiple myeloma treatment strategies with novel agents in 2011: A European perspective
Oncologist, Vol. 16, Núm. 4, pp. 388-403
2010
-
Current multiple myeloma treatment strategies with novel agents: A European perspective
Oncologist, Vol. 15, Núm. 1, pp. 6-25